Loading
Latest filing published 14 Dec 2021 for Clarus Therapeutics Holdings, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Frank Jaeger is known so far (14 December 2021): a share grant, in Clarus Therapeutics Holdings, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration